Related Experiment Video
Updated: Jan 11, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Contemporary Results of Intra-Arterial Thrombolysis for Acute and Acute-On-Chronic Lower Limb Ischemia
Roberto Falso1, Elena Giacomelli1, Walter Dorigo1
1Section of Vascular Surgery, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Insights
Catheter-directed thrombolysis (CDT) effectively treats infrainguinal arterial occlusions in acute limb ischemia (ALI) and acute-on-chronic limb ischemia (ACLI). While long-term patency is limited, CDT is a safe revascularization option, especially when combined with other procedures.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Cardiovascular Medicine
Background:
- Infrainguinal arterial occlusions causing acute limb ischemia (ALI) or acute-on-chronic limb ischemia (ACLI) require effective revascularization.
- Catheter-directed thrombolysis (CDT) is a potential treatment option, but its outcomes and safety in these specific settings need thorough evaluation.
Purpose of the Study:
- To assess the immediate and long-term efficacy of CDT for infrainguinal arterial occlusions in patients with ALI and ACLI.
- To evaluate the safety and durability of CDT across diverse clinical and anatomical presentations.
- To identify factors influencing patient outcomes following CDT.
Main Methods:
- Retrospective analysis of 128 patients undergoing CDT for infrainguinal occlusions (January 2014 - December 2024).
- Patients categorized into ALI (n=85) and ACLI (n=43) groups.
- Urokinase infusion via multihole catheters used for CDT; outcomes assessed via Kaplan-Meier analysis (patency, limb salvage, amputation-free survival, freedom from reintervention).
Main Results:
- CDT achieved technical success in 85.1% of patients, with comparable rates in ALI and ACLI.
- At 30 days, major amputation and mortality rates were 4.6% and 3.1%, respectively; three major bleeding events occurred.
- Five-year estimated survival was 74.2%; limb salvage was 79% (ALI) vs. 86% (ACLI), and amputation-free survival was 58.5% vs. 74%. Five-year primary patency was 22% (ALI) vs. 32.5% (ACLI), and secondary patency was 26% vs. 48%. Freedom from reintervention was 36% (ALI) vs. 43% (ACLI). Chronic kidney disease independently predicted adverse outcomes (HR: 2.9).
Conclusions:
- CDT is a safe and effective revascularization strategy for infrainguinal occlusions in both ALI and ACLI.
- Clinical presentation and lesion anatomy did not significantly impact outcomes, whereas comorbidities, particularly chronic kidney disease, strongly correlated with poor prognosis.
- Despite limited long-term patency, CDT is a valuable option for selected patients, especially when integrated with adjunctive endovascular or surgical techniques.
Background:
To evaluate the immediate and long-term outcomes of catheter-directed thrombolysis (CDT) in infrainguinal arterial occlusions presenting with acute limb ischemia (ALI) or acute-on-chronic limb ischemia (ACLI), and to assess its safety and durability across different clinical and anatomical settings.
Methods:
We retrospectively analyzed 128 consecutive patients who underwent initial CDT for infrainguinal occlusions between January 2014 and December 2024. Patients were divided into ALI (n = 85) and ACLI (n = 43). CDT was performed with urokinase infusion via multihole catheters. Technical success, complications, and adjunctive procedures were recorded. Long-term outcomes were assessed using Kaplan-Meier analysis, with primary end points including patency, limb salvage, amputation-free survival (AFS), and freedom from reintervention.
Results:
CDT was effective or partially effective in 109 patients (85.1%), with similar success rates in ALI and ACLI. At 30 days, major amputation and mortality rates were 4.6% and 3.1%, respectively. Three major bleeding events required thrombolysis discontinuation. The median follow-up was 36 months (range 1-120), with a follow-up index of 0.72. At 5 years, estimated survival was 74.2%. Limb salvage was 79% in ALI and 86% in ACLI (P = 0.5), and AFS was 58.5% versus 74% (P = 0.1). Primary and secondary patency at 5 years were 22% and 26% for ALI, and 32.5% and 48% for ACLI (P = 0.7 and P = 0.2). Freedom from reintervention was 36% for ALI and 43% for ACLI (P = 0.4). Chronic kidney disease was the only independent predictor of death or amputation (hazard ratio: 2.9; 95% confidence interval: 1.2-6.8).
Conclusion:
CDT is a safe and effective revascularization strategy for infrainguinal occlusions in both ALI and ACLI. Outcomes were not significantly influenced by clinical presentation or lesion anatomy, while comorbidities-particularly chronic kidney disease-were strongly associated with poor prognosis. Despite limited long-term patency, CDT remains a valuable option in selected patients, especially when combined with adjunctive endovascular or surgical approaches.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management

